Stereotactic Ablative Radiotherapy (SAbR) for Primary Renal Cell Carcinoma

Osama Mohamad; Robert D. Timmerman; Raquibul Hannan

doi:10.1007/978-3-030-16924-4_26

Stereotactic Ablative Radiotherapy (SAbR) for Primary Renal Cell Carcinoma

Osama Mohamad
, Robert D. Timmerman
, Raquibul Hannan

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Although renal cell cancer (RCC) was shown to be radioresistant to conventionally fractionated radiation therapy (RT) both in vitro and in vivo, mounting preclinical and clinical evidence suggests that it is quite sensitive to hypofractionated RT, particularly stereotactic ablative radiotherapy (SAbR). In the setting of primary RCC, SAbR has been applied effectively in multiple retrospective and early phase prospective trials with favorable toxicity. In this chapter, we will review the current literature and cover the technical considerations for the setup, treatment planning, and delivery of SAbR for primary RCC.

Original language	English (US)
Title of host publication	Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Subtitle of host publication	A Comprehensive Guide
Publisher	Springer International Publishing
Pages	307-317
Number of pages	11
ISBN (Electronic)	9783030169244
ISBN (Print)	9783030169237
DOIs	https://doi.org/10.1007/978-3-030-16924-4_26
State	Published - Jan 1 2019
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-030-16924-4_26

Cite this

@inbook{08748797dade49869604361016f1db6c,

title = "Stereotactic Ablative Radiotherapy (SAbR) for Primary Renal Cell Carcinoma",

abstract = "Although renal cell cancer (RCC) was shown to be radioresistant to conventionally fractionated radiation therapy (RT) both in vitro and in vivo, mounting preclinical and clinical evidence suggests that it is quite sensitive to hypofractionated RT, particularly stereotactic ablative radiotherapy (SAbR). In the setting of primary RCC, SAbR has been applied effectively in multiple retrospective and early phase prospective trials with favorable toxicity. In this chapter, we will review the current literature and cover the technical considerations for the setup, treatment planning, and delivery of SAbR for primary RCC.",

author = "Osama Mohamad and Timmerman, \{Robert D.\} and Raquibul Hannan",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2019.",

year = "2019",

month = jan,

day = "1",

doi = "10.1007/978-3-030-16924-4\_26",

language = "English (US)",

isbn = "9783030169237",

pages = "307--317",

booktitle = "Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Stereotactic Ablative Radiotherapy (SAbR) for Primary Renal Cell Carcinoma

AU - Mohamad, Osama

AU - Timmerman, Robert D.

AU - Hannan, Raquibul

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2019.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Although renal cell cancer (RCC) was shown to be radioresistant to conventionally fractionated radiation therapy (RT) both in vitro and in vivo, mounting preclinical and clinical evidence suggests that it is quite sensitive to hypofractionated RT, particularly stereotactic ablative radiotherapy (SAbR). In the setting of primary RCC, SAbR has been applied effectively in multiple retrospective and early phase prospective trials with favorable toxicity. In this chapter, we will review the current literature and cover the technical considerations for the setup, treatment planning, and delivery of SAbR for primary RCC.

AB - Although renal cell cancer (RCC) was shown to be radioresistant to conventionally fractionated radiation therapy (RT) both in vitro and in vivo, mounting preclinical and clinical evidence suggests that it is quite sensitive to hypofractionated RT, particularly stereotactic ablative radiotherapy (SAbR). In the setting of primary RCC, SAbR has been applied effectively in multiple retrospective and early phase prospective trials with favorable toxicity. In this chapter, we will review the current literature and cover the technical considerations for the setup, treatment planning, and delivery of SAbR for primary RCC.

UR - https://www.scopus.com/pages/publications/105011002436

UR - https://www.scopus.com/pages/publications/105011002436#tab=citedBy

U2 - 10.1007/978-3-030-16924-4_26

DO - 10.1007/978-3-030-16924-4_26

M3 - Chapter

AN - SCOPUS:105011002436

SN - 9783030169237

SP - 307

EP - 317

BT - Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy

PB - Springer International Publishing

ER -

Stereotactic Ablative Radiotherapy (SAbR) for Primary Renal Cell Carcinoma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this